{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-295457","form_type":"8-K","ticker":"BEAM","cik":"0001745999","company_name":"Beam Therapeutics Inc.","filed_at":"2023-12-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.294531+00:00","generated_at":"2026-06-07T12:55:18.187926+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Beam Therapeutics appoints Christi Shaw, former Kite CEO, to board of directors","bullets":["Board expanded from 7 to 8 members; Shaw appointed as Class III director with term until 2026.","Shaw brings over 30 years biopharma experience, most recently CEO of Kite (Gilead) until March 2023.","Previously held senior roles at Lilly, Novartis, and Johnson & Johnson; currently on Avantor board.","Shaw will receive compensation per company's non-employee director policy dated March 31, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-295457","json":"https://secwatch.observer/filing/0001193125-23-295457.json","markdown":"https://secwatch.observer/filing/0001193125-23-295457.md","text":"https://secwatch.observer/filing/0001193125-23-295457.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1745999/000119312523295457/0001193125-23-295457-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1745999/000119312523295457/d523217d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T12:55:18.187926+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"96d9ff1d13","claim":"Christi Shaw was elected as member of the Board at Beam Therapeutics Inc..","evidence_excerpt":"On December 13, 2023, the Board of Directors (the “Board”) of Beam Therapeutics Inc. (the “Company”), upon recommendation from the Nominating and Corporate Governance Committee of the Board, expanded the size of the Board from seven to eight members and elected Christi Shaw as a member of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312523295457/0001193125-23-295457-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"member of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}